Concepedia

Yury Valdés-Balbín

YV

Statistics

Publications

19

Citations

628

H-Index

14

Active since

2016

Affiliations

Finlay Institute(Current)

Center of Molecular Immunology (Cuba)

State Key Laboratory of Biotherapy

Sichuan University

Cuban Neuroscience Center

Yury Valdés-Balbín is an author at Finlay Institute specializing in medicine, vaccination, and vaccine safety.

ORCID

Top concepts

Publications per year

2016–2022

19

Publications

19

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero et al. · ACS Chemical Biology · 2021 · 88 citations · Full text

, , +13

Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota

Fabrizio Chiodo, Sven C. M. Bruijns, Ernesto Rodríguez et al. · 2020 · 81 citations · Full text

, , +18

Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction

Qingju Zhang, Ana Gimeno, Darielys Santana-Mederos et al. · ACS Central Science · 2019 · 69 citations · Full text

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva et al. · The Lancet Regional Health - Americas · 2022 · 44 citations · Full text

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · The Lancet Regional Health - Americas · 2021 · 40 citations · Full text

1–5 of 19